Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.56    0.28 (6.54%)
Bid:
4.40
Ask:
4.54
Spread: 0.14 (3.182%)
Market Cap: £39.66m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Directorate Change

17 Apr 2025 07:00

RNS Number : 3893F
Revolution Beauty Group PLC
17 April 2025
Β 

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

Directorate Change

Revolution Beauty Group, the multi-channel mass beauty brand, today announces that Lauren Brindley will stand down as Group Chief Executive Officer (CEO) and as a member of the Board on 31 May 2025. Lauren will be taking up the role of Chief Merchandising and Digital Officer at Ulta Beauty, Inc., the largest beauty retailer in the United States.

Upon Lauren's departure, Colin Henry will become interim CEO. Colin has been a Non-Executive Director of Revolution Beauty since August 2023, and has over 35 years of consumer goods and retail experience having held leadership roles at Jaeger, Espirit, Nike, Umbro, Polo Ralph Lauren and M&S. He is currently a Non-Executive Director of New Look.

A process to find a permanent CEO has now commenced and is being led by the Group Nominations Committee. Lauren will be working with Colin to ensure a seamless transition prior to beginning her new role.

Alistair McGeorge, Revolution Beauty Chairman, commented: "On behalf of the Board, I would like to thank Lauren for her considerable contribution to Revolution Beauty. We now have a clear strategy, a stronger management team, more efficient operations, and a sustainable financial model. Lauren leaves the Group well-placed for future success and we wish her all the best in her new role. Colin's time on the Board, which played a key role in defining the Group's new strategy, and his significant sector experience mean he is very well suited to take up the position of interim CEO."

Lauren Brindley, Revolution Beauty CEO, commented: "It has been a privilege to lead Revolution Beauty and our brilliant team. This is a business with unique capabilities, a loyal customer base and now a compelling strategy for future growth. I am confident that the focus on the Masterbrand and our core portfolio of products will continue to deliver benefits and I look forward to following the Group's success in the future."

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

For further informationΒ please contact:

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

Panmure Liberum Limited (Nomad and Joint Broker):Β Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

Zeus (Joint Broker):Β Benjamin Robertson / Nick Cowles / Jordan Warburton

Tel: +44 (0) 161 831 1512

Media enquiries

Headland Consultancy:Β Matt Denham / Antonia Pollock

Tel: +44 (0)77 899 54356

Revolutionbeauty@headlandconsultancy.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAGPUAACUPAPWQ
Date   Source Headline
30th Mar 20237:00 amRNSUpdate on timing of FY22 Results and Financing
7th Mar 20232:00 pmRNSRevised deferred consideration for Medichem
21st Feb 20237:00 amRNSUpdate on FY22 Audit
13th Jan 20237:00 amRNSOutcome of Independent Investigation
16th Dec 20222:35 pmRNSDirectorate Change
28th Nov 20222:24 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSAppointment of CEO
25th Nov 20224:27 pmRNSTR-1: Standard notification of major holdings
9th Nov 20229:05 amRNSDirectorate Change
27th Oct 20225:30 pmRNSSuspended Companies Notice – Deletions
14th Oct 20227:00 amRNSUpdate on Independent Investigation
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
7th Sep 20227:00 amRNSTR-1: Standard notification of major holdings
1st Sep 20227:30 amRNSSuspension - Revolution Beauty Group plc
30th Aug 20227:00 amRNSUpdate on Publication of Final Results
19th Aug 20222:30 pmRNSFurther update on the Group’s audit
17th Aug 20226:20 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:15 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:00 pmRNSTR-1: Standard notification of major holdings
17th Aug 20227:05 amRNSStrategic Investment in Revolution Beauty Group
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
12th Aug 20221:55 pmRNSTR-1: Standard notification of major holdings
11th Aug 20224:41 pmRNSSecond Price Monitoring Extn
11th Aug 20224:35 pmRNSPrice Monitoring Extension
11th Aug 202211:05 amRNSUpdate on the Group’s audit
11th Aug 202210:10 amRNSTR-1: Standard notification of major holdings
5th Aug 20221:20 pmRNSTR-1: Standard notification of major holdings
3rd Aug 20223:45 pmRNSTR-1 Standard notification of major holdings
2nd Aug 20227:00 amRNSTrading update and change to results date
30th Jun 20227:00 amRNSCorporate Broker Appointment and Notice of Results
17th Jun 20227:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
12th May 20227:00 amRNSAppointment of Chief Financial Officer
11th May 202211:40 amRNSHolding(s) in Company
6th May 20227:00 amRNSFull Year Trading Update
25th Feb 20227:00 amRNSAcquisition
23rd Feb 20225:50 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSTrading Update
24th Nov 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSAcquisition of Medichem Manufacturing
27th Sep 20217:00 amRNSH1 Trading Update and Notice of Results
20th Aug 202111:47 amRNSIssue of Shares under Share Incentive Plan & TVR
23rd Jul 202112:08 pmRNSImplementation of Long Term Incentive Plan
22nd Jul 20215:35 pmRNSNotification of Major Holdings
21st Jul 20217:00 amRNSNotification of Major Holdings
20th Jul 20215:59 pmRNSDirector Dealing
19th Jul 20217:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.